cgp 39551 has been researched along with Action Tremor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halsey, MJ; Henley, M; Maclean, CJ; Meldrum, BS; Pearce, PC; Pearson, J; Ward, EM | 1 |
1 other study(ies) available for cgp 39551 and Action Tremor
| Article | Year |
|---|---|
The orally active NMDA receptor antagonist CGP 39551 ameliorates the high pressure neurological syndrome in Papio anubis.
Topics: 2-Amino-5-phosphonovalerate; Administration, Oral; Animals; Anticonvulsants; Electroencephalography; Female; High Pressure Neurological Syndrome; Male; Papio; Receptors, N-Methyl-D-Aspartate; Seizures; Tremor | 1993 |